[ FDA · GUIDANCE DOCUMENTS ]

What the FDA is telling industry to do next.

FDA guidance documents set the Agency’s current thinking — and draft guidance signals where expectations are heading before they are final. Much of it never appears in the Federal Register. SPEQ tracks the newest draft and final guidances with their issue date, status, and a link to each.

29
Guidances tracked
Sep 8, 2026
Most recent
8 draft · 21 final
Status split

How to use this library

Start with Status — a draft signals where FDA expectations are heading, a final one states them. Then narrow by topic or year. Each row opens the guidance record with its issue date, status and a link to FDA’s own document.

SPEQ reproduces FDA guidance metadata as published and adds no interpretation. A guidance document represents the Agency’s current thinking; it does not establish legally enforceable responsibilities unless a specific regulatory requirement is cited.

New to GxP? Start with Navigator →
29 guidance documents
Newest first
COMPLETE INDEX — ALL 29 GUIDANCE DOCUMENT

Every count on this page is derived from the fda_guidance table at render — none is a literal. Follow each source link for FDA’s authoritative document.

Source: FDA guidance database (fda.gov), scraped and refreshed daily. Only rows verified against the live page are stored (a markdown-verification guard). Guidances are FDA records reproduced as published — SPEQ adds no interpretation. The archive builds forward from the first scan.